» Articles » PMID: 1238311

Mast Cells and Immunoglobulin E in Inflammatory Bowel Disease

Overview
Journal Gut
Specialty Gastroenterology
Date 1975 Nov 1
PMID 1238311
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

The numbers of mast cells and of IgE-containing immunocytes in the bowel wall of patients suffering from Crohn's disease of ulcerative colitis have been estimated and the results compared with those found in normal control specimens. In ulcerative colitis there is a slight rise in the number of mast cells and it appears that these participate in the inflammatory process in a non-specific manner; the number of IgE-containing immunocytes is not significantly altered. In Crohn's disease there is an almost total absence of stainable mast cells in affected areas of the bowel, together with a marked decrease in IgE-containing immunocytes. It is suggested that these findings are due to degranulation of mast cells and consumption of IgE as a result of an immediate hypersensitivity reaction in the bowel wall, this being one component of the protein inflammatory and immunological response to the entry of a variety of antigenic material.

Citing Articles

Potential pitfalls in reporting non-neoplastic gastrointestinal mucosal biopsies.

Al-Qudah M, Murshed K, Haddad H, Haboubi N Histol Histopathol. 2023; 38(12):1359-1372.

PMID: 37288819 DOI: 10.14670/HH-18-632.


IgE-Dependent Food Sensitisation and Its Role in Clinical and Laboratory Presentation of Paediatric Inflammatory Bowel Disease.

Buczynska A, Grzybowska-Chlebowczyk U, Pawlicki K Nutrients. 2023; 15(8).

PMID: 37111022 PMC: 10145321. DOI: 10.3390/nu15081804.


Mast Cells as Important Regulators in Autoimmunity and Cancer Development.

Noto C, Hoft S, DiPaolo R Front Cell Dev Biol. 2021; 9:752350.

PMID: 34712668 PMC: 8546116. DOI: 10.3389/fcell.2021.752350.


Increased Colonic Epithelial Permeability and Mucosal Eosinophilia in Ulcerative Colitis in Remission Compared With Irritable Bowel Syndrome and Health.

Katinios G, Casado-Bedmar M, Walter S, Vicario M, Gonzalez-Castro A, Bednarska O Inflamm Bowel Dis. 2020; 26(7):974-984.

PMID: 31944236 PMC: 7301402. DOI: 10.1093/ibd/izz328.


Regional specialization within the intestinal immune system.

Mowat A, Agace W Nat Rev Immunol. 2014; 14(10):667-85.

PMID: 25234148 DOI: 10.1038/nri3738.


References
1.
Green F, Fox H . The distribution of mucosal antibodies in the bowel of patients with Crohn's disease. Gut. 1975; 16(2):125-31. PMC: 1410987. DOI: 10.1136/gut.16.2.125. View

2.
Rao S . Mast cells as a component of the granuloma in Crohn's disease. J Pathol. 1973; 109(1):79-82. DOI: 10.1002/path.1711090109. View

3.
RANLOV P, Nielsen M, WANSTRUP J . Ultrastructure of the ileum in Crohn's disease. Immune lesions and mastocytosis. Scand J Gastroenterol. 1972; 7(5):471-6. DOI: 10.3109/00365527209180772. View

4.
SOMMERS S . Mast cells and paneth cells in ulcerative colitis. Gastroenterology. 1966; 51(5):841-50. View

5.
McGOVERN V, Archer G . The pathogenesis of ulcerative colitis. Australas Ann Med. 1957; 6(1):68-74. DOI: 10.1111/imj.1957.6.1.68. View